US Health & Fitness
Regulatory pressure is mounting on Amgen’s inflammatory disorder drug, Tavneos, with the European Medicines Agency recommending revocation of the product’s approval in its territory.…
By KIM BELLARD It probably didn’t show up on your calendar, but Monday was World…
A little over a week after CMS announced significant changes to Medicaid work requirements set…
Sometimes the most meaningful moments of care happen when someone simply takes the time to…
A Novartis RNA therapy reduced blood levels of a protein that’s a biological indicator of…
Over the past two years, much of the conversation around AI in digital behavioral health…
In the employer benefits work I do, I watch plan sponsors absorb cost increases they…
